Conmed Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
January 27, 2021 at 09:35 pm
Share
CONMED Corporation announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced sales was USD 252.828 million compared to USD 264.865 million a year ago. Operating income was USD 24.701 million compared to USD 27.879 million a year ago. Net income was USD 24.140 million compared to USD 14.933 million a year ago. Basic earnings per share from continuing operations was USD 0.84 compared to USD 0.53 a year ago. Diluted earnings per share from continuing operations was USD 0.81 compared to USD 0.49 a year ago. For the full year, sales was USD 862.459 million compared to USD 955.097 million a year ago. Operating income was USD 46.010 million compared to USD 79.114 million a year ago. Net income was USD 9.517 million compared to USD 28.620 million a year ago. Basic earnings per share from continuing operations was USD 0.33 compared to USD 1.01 a year ago. Diluted earnings per share from continuing operations was USD 0.32 compared to USD 0.97 a year ago.
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
CONMED CORPORATION 
